• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of amjpatholAmerican Journal of Pathology For AuthorsAmerican Journal of Pathology SubscribeAmerican Journal of Pathology SearchAmerican Journal of Pathology Current IssueAmerican Journal of Pathology About the JournalAmerican Journal of Pathology
Am J Pathol. Mar 1986; 122(3): 410–420.
PMCID: PMC1888226

The pathogenesis of hyaline arteriolosclerosis.

Abstract

Although hyaline arteriolosclerosis is very common and has been of interest to pathologists for well over 100 years, its pathogenesis has never been determined. This study demonstrates that iC3b bound via an ester linkage to hydroxyl groups on the repeating disaccharide units of hyaluronic acid is a major component of arteriolar hyaline. The deposition of iC3b within the walls of arterioles appears to be due to slow spontaneous activation of the alternative complement pathway and random binding of metastable C3b to proximate hyaluronic acid within the arteriolar wall. Since hyaluronic acid does not activate the alternative complement pathway, bound C3b is rapidly inactivated by factors I and H to iC3b, which, along with factor H, remains bound to hyaluronic acid. The hyaline in some hyalinized arterioles also contains IgM and early and late classical complement pathway components. Indirect evidence suggests that the IgM represents immunoconglutinin, an autoantibody to neoantigens on iC3b and that their interaction results in activation of the classical complement pathway. The gradual accumulation of iC3b, factor H, and, at times, IgM and classical complement pathway components within the walls of arterioles is considered to be a physiologic consequence of aging and probably cannot be prevented, because interruption of the initial binding of metastable C3b to hyaluronic acid would require abrogation of the critically important functions of the alternative complement pathway.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.8M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Moritz AR, Oldt MR. Arteriolar Sclerosis in Hypertensive and Non-Hypertensive Individuals. Am J Pathol. 1937 Sep;13(5):679–728.7. [PMC free article] [PubMed]
  • DUSTIN P, Jr, BARTMAN J. [Anatomo-clinical research on splenic hyalinosis in the child]. Rev Belg Pathol Med Exp. 1961 Jul;28:152–170. [PubMed]
  • SMITH JP. Hyaline arteriolosclerosis in the kidney. J Pathol Bacteriol. 1955 Jan-Apr;69(1-2):147–168. [PubMed]
  • BELL ET. Renal vascular disease in diabetes mellitus. Diabetes. 1953 Sep-Oct;2(5):376–389. [PubMed]
  • Gull WW, Sutton HG. On the Pathology of the Morbid State commonly called Chronic Bright's Disease with Contracted Kidney, ("Arterio-capillary Fibrosis."). Med Chir Trans. 1872;55:273–330.1. [PMC free article] [PubMed]
  • MONTGOMERY PO, MUIRHEAD EE. A characterization of hyaline arteriolar sclerosis by histochemical procedures. Am J Pathol. 1954 May-Jun;30(3):521–531. [PMC free article] [PubMed]
  • CRAWFORD T, WOOLF N. Hyaline arteriolosclerosis in the spleen: an immuno-histochemical study. J Pathol Bacteriol. 1960 Apr;79:221–225. [PubMed]
  • LENDRUM AC. The hypertensive diabetic kidney as a model of the so-called collagen diseases. Can Med Assoc J. 1963 Mar 2;88:442–452. [PMC free article] [PubMed]
  • BIAVA CG, DYRDA I, GENEST J, BENCOSME SA. RENAL HYALINE ARTERIOLOSCLEROSIS. AN ELECTRON MICROSCOPE STUDY. Am J Pathol. 1964 Mar;44:349–363. [PMC free article] [PubMed]
  • Fisher ER, Perez-Stable E, Pardo V. Ultrastructural studies in hypertension. I. Comparison of renal vascular and juxtaglomerular cell alterations in essential and renal hypertension in man. Lab Invest. 1966 Sep;15(9):1409–1433. [PubMed]
  • MCGEE WG, ASHWORTH CT. FINE STRUCTURE OF CHRONIC HYPERTENSIVE ARTERIOPATHY IN THE HUMAN KIDNEY. Am J Pathol. 1963 Aug;43:273–299. [PMC free article] [PubMed]
  • WIENER J, SPIRO D, LATTES RG. THE CELLULAR PATHOLOGY OF EXPERIMENTAL HYPERTENSION. II. ARTERIOLAR HYALINOSIS AND FIBRINOID CHANGE. Am J Pathol. 1965 Sep;47:457–485. [PMC free article] [PubMed]
  • DUGUID JB, ANDERSON GS. The pathogenesis of hyaline arteriolosclerosis. J Pathol Bacteriol. 1952 Jul;64(3):519–522. [PubMed]
  • STILL WJ, HILL KR. The pathogenesis of hyaline arteriolar sclerosis. AMA Arch Pathol. 1959 Jul;68(1):42–48. [PubMed]
  • MUIRHEAD EE, TURNER LB, GROLLMAN A. Hypertensive cardiovascular disease; nature and pathogenesis of the arteriolar sclerosis induced by bilateral nephrectomy as revealed by a study of its tinctorial characteristics. AMA Arch Pathol. 1951 Sep;52(3):266–279. [PubMed]
  • Valenzuela R, Gogate PA, Deodhar SD, Gifford RW. Hyaline arteriolar nephrosclerosis. Immunofluorescence findings in the vascular lesions. Lab Invest. 1980 Dec;43(6):530–534. [PubMed]
  • Naish PF, Aber GM, Boyd WN. C3 deposition in renal arterioles in the loin pain and haematuria syndrome. Br Med J. 1975 Sep 27;3(5986):746–746. [PMC free article] [PubMed]
  • Orfila C, Pieraggi MT, Suc JM. Mesangial isolated C3 deposition in patients with recurrent or persistent hematuria. Lab Invest. 1980 Jul;43(1):1–8. [PubMed]
  • Grekas D, Morley AR, Wilkinson R, Kerr DN. Isolated C3 deposition in patients without systemic disease. Clin Nephrol. 1984 May;21(5):270–274. [PubMed]
  • Gamble CN, Reardan JB. Immunopathogenesis of syphilitic glomerulonephritis. Elution of antitreponemal antibody from glomerular immune-complex deposits. N Engl J Med. 1975 Feb 27;292(9):449–454. [PubMed]
  • Hadley WK, Rosenau W. Study of human renal disease by immunofluorescent methods. Arch Pathol. 1967 Apr;83(4):342–351. [PubMed]
  • Gamble CN, Kimchi A, Depner TA, Christensen D. Immune complex glomerulonephritis and dermal vasculitis following intestinal bypass for morbid obesity. Am J Clin Pathol. 1982 Mar;77(3):347–352. [PubMed]
  • Tamerius JD, Pangburn MK, Müller-Eberhard HJ. Detection of a neoantigen on human C3bi and C3d by monoclonal antibody. J Immunol. 1985 Sep;135(3):2015–2019. [PubMed]
  • Gamble CN, Ruggles SW. The immunopathogenesis of glomerulonephritis associated with mixed cryoglobulinemia. N Engl J Med. 1978 Jul 13;299(2):81–84. [PubMed]
  • Müller-Eberhard HJ, Schreiber RD. Molecular biology and chemistry of the alternative pathway of complement. Adv Immunol. 1980;29:1–53. [PubMed]
  • Carlo JR, Ruddy S, Sauter S, Yount WJ. Deposition of beta 1H globulin in kidneys of patients with immune renal disease. Arthritis Rheum. 1979 Apr;22(4):403–411. [PubMed]
  • Gaither TA, Hammer CH, Frank MM. Studies of the molecular mechanisms of C3b inactivation and a simplified assay of beta 1H and the C3b inactivator (C3bINA). J Immunol. 1979 Sep;123(3):1195–1204. [PubMed]
  • Carlo JR, Ruddy S, Studer EJ, Conrad DH. Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin. J Immunol. 1979 Aug;123(2):523–528. [PubMed]
  • Williams JD, Czop JK, Abrahamson DR, Davies M, Austen KF. Activation of the alternative complement pathway by isolated human glomerular basement membrane. J Immunol. 1984 Jul;133(1):394–399. [PubMed]
  • Ausprunk DH, Boudreau CL, Nelson DA. Proteoglycans in the microvasculature. I. Histochemical localization in microvessels of the rabbit eye. Am J Pathol. 1981 Jun;103(3):353–366. [PMC free article] [PubMed]
  • Law SK, Minich TM, Levine RP. Binding reaction between the third human complement protein and small molecules. Biochemistry. 1981 Dec 22;20(26):7457–7463. [PubMed]
  • LUDOWIEG J, VENNESLAND B, DORFMAN A. The mechanism of action of hyaluronidase. J Biol Chem. 1961 Feb;236:333–339. [PubMed]
  • Ohya T, Kaneko Y. Novel hyaluronidase from streptomyces. Biochim Biophys Acta. 1970 Mar 18;198(3):607–609. [PubMed]
  • Yamada K. The effect of digestion with Streptomyces hyaluronidase upon certain histochemical reactions of hyaluronic acid-containing tissues. J Histochem Cytochem. 1973 Sep;21(9):794–803. [PubMed]
  • Derby MA, Pintar JE. The histochemical specificity of Streptomyces hyaluronidase and chondroitinase ABC. Histochem J. 1978 Sep;10(5):529–547. [PubMed]
  • Law SK, Levine RP. Interaction between the third complement protein and cell surface macromolecules. Proc Natl Acad Sci U S A. 1977 Jul;74(7):2701–2705. [PMC free article] [PubMed]
  • Law SK, Lichtenberg NA, Levine RP. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces. J Immunol. 1979 Sep;123(3):1388–1394. [PubMed]
  • Law SK, Lichtenberg NA, Levine RP. Covalent binding and hemolytic activity of complement proteins. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7194–7198. [PMC free article] [PubMed]
  • Venkatesh YP, Minich TM, Law SK, Levine RP. Natural release of covalently bound C3b from cell surfaces and the study of this phenomenon in the fluid-phase system. J Immunol. 1984 Mar;132(3):1435–1439. [PubMed]
  • Mayer MM. Complement. Historical perspectives and some current issues. Complement. 1984;1(1):2–26. [PubMed]
  • Nag S, Robertson DM, Dinsdale HB. Intracerebral arteriolar permeability to lanthanum. Am J Pathol. 1982 Jun;107(3):336–341. [PMC free article] [PubMed]
  • Hüttner I, Boutet M, More RH. Studies on protein passage through arterial endothelium. II. Regional differences in permeability to fine structural protein tracers in arterial endothelium of normotensive rat. Lab Invest. 1973 Jun;28(6):678–685. [PubMed]
  • Janatova J, Lorenz PE, Schechter AN, Prahl JW, Tack BF. Third component of human complement: appearance of a sulfhydryl group following chemical or enzymatic inactivation. Biochemistry. 1980 Sep 16;19(19):4471–4478. [PubMed]
  • Janatova J, Tack BF, Prahl JW. Third component of human complement: structural requirements for its function. Biochemistry. 1980 Sep 16;19(19):4479–4485. [PubMed]
  • Tack BF, Harrison RA, Janatova J, Thomas ML, Prahl JW. Evidence for presence of an internal thiolester bond in third component of human complement. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5764–5768. [PMC free article] [PubMed]
  • Harrison RA, Thomas ML, Tack BF. Sequence determination of the thiolester site of the fourth component of human complement. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7388–7392. [PMC free article] [PubMed]
  • Campbell RD, Gagnon J, Porter RR. Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. Biochem J. 1981 Nov 1;199(2):359–370. [PMC free article] [PubMed]
  • Pangburn MK, Müller-Eberhard HJ. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement. J Exp Med. 1980 Oct 1;152(4):1102–1114. [PMC free article] [PubMed]
  • Pangburn MK, Schreiber RD, Müller-Eberhard HJ. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J Exp Med. 1981 Sep 1;154(3):856–867. [PMC free article] [PubMed]
  • Isenman DE, Kells DI, Cooper NR, Müller-Eberhard HJ, Pangburn MK. Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties. Biochemistry. 1981 Jul 21;20(15):4458–4467. [PubMed]
  • Pangburn MK. Activation of complement via the alternative pathway. Fed Proc. 1983 Jan;42(1):139–143. [PubMed]
  • Fishelson Z, Pangburn MK, Müller-Eberhard HJ. Characterization of the initial C3 convertase of the alternative pathway of human complement. J Immunol. 1984 Mar;132(3):1430–1434. [PubMed]
  • Sim RB, Twose TM, Paterson DS, Sim E. The covalent-binding reaction of complement component C3. Biochem J. 1981 Jan 1;193(1):115–127. [PMC free article] [PubMed]
  • Rodén L, Koerner T, Olson C, Schwartz NB. Mechanisms of chain initiation in the biosynthesis of connective tissue polysaccharides. Fed Proc. 1985 Feb;44(2):373–380. [PubMed]
  • Poulsen HL. Subcutaneous interstitial fluid concentrations of albumin and immunoglobulin G in relation to the serum values in normal, hypertensive and diabetic men. Bibl Anat. 1975;13:74–75. [PubMed]
  • Parving HH. Microvascular permeability to plasma proteins in hypertension and diabetes mellitus in man--on the pathogenesis of hypertensive and diabetic microangiopathy. Dan Med Bull. 1975 Sep;22(6):217–233. [PubMed]
  • Ditzel J. Functional microangiopathy in diabetes mellitus. Diabetes. 1968 Jun;17(6):388–397. [PubMed]
  • Bollinger A, Frey J, Jäger K, Furrer J, Seglias J, Siegenthaler W. Patterns of diffusion through skin capillaries in patients with long-term diabetes. N Engl J Med. 1982 Nov 18;307(21):1305–1310. [PubMed]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...